Supplementary Table 2 from A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors

Autor: Udai Banerji, Johann S. de Bono, T.R. Jeffry Evans, John Camm, Charles Phelps, Ann Forslund, Johan W. Smit, Steve Mcclue, Yusri Elsayed, Peter Hellemans, Nele Fourneau, Adam Stewart, Richard Cowan, Ruth Plummer, Rebecca S. Kristeleit, Richard Baird, Balaji Venugopal
Rok vydání: 2023
Popis: Supplementary Table 2 - PDF file 58K, A summary of PK parameters of quisinostat estimated on day 1
Databáze: OpenAIRE